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Background: Cognitive impairment is common after acute ischemic stroke, affecting up to 75% of the patients. About half of
the patients will show recovery, whereas the others will remain cognitively impaired or deteriorate. It is difficult to predict these
different cognitive outcomes.
Objective: The objective of this study is to investigate whether diffusion tensor imaging–based measures of brain connectivity
predict cognitive recovery after 1 year, in addition to patient characteristics and stroke severity. A specific premise of the Prediction
of Cognitive Recovery After Stroke (PROCRAS) study is that it is conducted in a daily practice setting.
Methods: The PROCRAS study is a prospective, mono-center cohort study conducted in a large teaching hospital in the
Netherlands. A total of 350 patients suffering from an ischemic stroke who screen positive for cognitive impairment on the
Montreal Cognitive Assessment (MoCA<26) in the acute stage will undergo a 3Tesla-Magnetic Resonance Imaging (3T-MRI)
with a diffusion-weighted sequence and a neuropsychological assessment. Patients will be classified as being unimpaired, as
having a mild vascular cognitive disorder, or as having a major vascular cognitive disorder. One year after stroke, patients will
undergo follow-up neuropsychological assessment. The primary endpoint is recovery of cognitive function 1 year after stroke in
patients with a confirmed poststroke cognitive disorder. The secondary endpoint is deterioration of cognitive function in the first
year after stroke.
Results: The study is already ongoing for 1.5 years, and thus far, 252 patients have provided written informed consent. Final
results are expected in June 2019.
Conclusions: The PROCRAS study will show the additional predictive value of diffusion tensor imaging-based measures of
brain connectivity for cognitive outcome at 1 year in patients with a poststroke cognitive disorder in a daily clinical practice
setting.
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Introduction
Stroke has a high global incidence of 41-316 per 100,000
persons per year [1]. Besides its physical consequences,
cognitive deficits are common and occur in up to 75% of patients
in the first weeks after stroke [2-5]. In half of the patients,
cognition may improve [3,6]. Yet, long-term cognitive
consequences of stroke include a twofold increased risk of
dementia [7-9] and mild cognitive impairment [6]. Identification
of those who will recover or who will have persistent cognitive
impairment is important, as persistent cognitive dysfunction
after stroke is independently correlated with worse long-term
outcomes, such as independent living, community reintegration,
and quality of life [10-14]. Moreover, recovery may be
stimulated further in patients who are prone to improvement.
For example, rehabilitation programs could use this information
in setting realistic and attainable therapeutic goals.
Prediction of long-term cognitive outcome after ischemic stroke
is, however, still inaccurate. Evidence is emerging on predictors
of poor outcome, including demographic variables (eg, older
age and lower level of education [2,3]). Brain imaging measures
such as size and location of a stroke, the degree of white matter
disease, and regional atrophy [15-21] may also determine
cognitive function and long-term outcome after stroke. In
contrast, fewer studies have addressed predictors of cognitive
recovery among individuals with early poststroke impairment.
Factors that have a positive effect on cognitive recovery are a
stroke located in the right hemisphere and smoking [22,23],
whereas neglect, depression, and apathy have a negative
influence on cognitive recovery [23-25].
Measures of brain connectivity are of particular interest in this
context. Stroke not only affects local connectivity but can also
cause remote brain changes, as shown by functional MRI and
diffusion tensor imaging (DTI) studies [26]. The value of brain
connectivity measures has already been established for the
prediction of motor recovery [27,28]. Conceivably, the relevance
of measures of brain connectivity in vascular cognitive disorders
(VCD) is also increasingly recognized. For example, global
network efficiency assessed with DTI has been independently
associated with cognitive performance in patients with cerebral
small vessel disease [29-32]. Moreover, brain connectivity
measures are correlated with cognition and intelligence in
healthy controls [33,34] and have been suggested to provide an
indication of brain resilience [34]. As such, it can be
hypothesized that these measures could predict cognitive
recovery after stroke. A recent study supporting this hypothesis
showed that brain connectivity measures predict applied
cognitive functioning 6 months after stroke [35]. Moreover,
another study showed that an increased structural integrity of
the contralesional hemisphere was associated with cognitive
recovery after stroke [36].
The primary aim of the Prediction of Cognitive Recovery After
Stroke (PROCRAS) study is to investigate whether DTI-based
measures of brain connectivity predict cognitive recovery in
the first year after stroke in patients with a confirmed poststroke
cognitive disorder in addition to clinical, neuropsychological,
and conventional imaging variables. Secondary aims are to
assess the relation of DTI-based measures of brain connectivity
with other outcomes. These other outcomes include deterioration
of cognitive function, cognitive complaints, quality of life,
participation, global health, and functional outcome. PROCRAS
will also assess the feasibility of an extensive work-up including
cognitive assessment and DTI in daily clinical practice.
Methods
Design
The PROCRAS study is a longitudinal, prospective, mono-center
cohort study of cognition in patients with acute ischemic stroke,
who will be followed for 1 year using 5 assessments.
Patient Population
Patients will be recruited from the stroke unit of the
Elisabeth-Tweesteden Hospital Tilburg, the Netherlands. This
is a hospital with an admission rate of approximately 700
patients per year for the diagnosis of acute ischemic stroke.
Figure 1 visualizes the anticipated patient flow; the numbers
are estimated and based on unpublished pilot data and a
feasibility study performed in Heidelberg [37]. In all patients
admitted with a clinical diagnosis of acute ischemic stroke, aged
50 years or older, the Montreal Cognitive Assessment (MoCA)
[38] is administered as part of routine care. Patients with a score
below 26 (screen positive) are eligible for inclusion (Textbox
1). MoCA assessment will be reattempted if at first patients are
untestable. Exclusion criteria are prestroke dementia (known
diagnosis of dementia or Informant Questionnaire on Cognitive
Decline in the Elderly (IQCODE≥3.6) [39]; life expectancy of
less than 1 year; severe stroke expected to require long-term
nursing care facilities, making patients not eligible for
rehabilitation therapy; history of major neurological disease
interfering with cognitive functioning; prestroke dependence
in activities of daily living; insufficient command of the Dutch
language; inability to participate in a neuropsychological
assessment (eg, due to poor vision, severe aphasia, or if the
patient is deemed untestable); and an impossibility to undergo
an MRI of the brain (Textbox 2). If there is no information
regarding the IQCODE, the researchers will discuss with the
attending physician whether there are signs of pre-existing
cognitive dysfunction. Only if there is no suspicion of prestroke
dementia, patients are eligible for inclusion.
Additionally, 60 patients with a MoCA score of 26 or higher
(screen negative) will be included as a reference group, matched
for age and gender to the screen-positive patients (frequency
matching). For this reference group, the other inclusion and
exclusion criteria and study procedures are identical to the
screen-positive patients.
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Figure 1. The expected patient flow in the Prediction of Cognitive Recovery After Stroke (PROCRAS) study. The target is to include 300 screen-positive
patients at T2. Other numbers are estimated based on this target (MoCA: Montreal cognitive assessment; MRI: magnetic resonance imaging).
Textbox 1. Inclusion criteria.
• Clinical diagnosis of ischemic stroke
• Age ≥50 years
• Montreal Cognitive Assessment (MoCA) <26 (MoCA≥26 for the reference group)
Textbox 2. Exclusion criteria.
• Prestroke dementia: Known diagnosis of dementia or Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) ≥3.6
• Life expectancy <1 year
• Severe stroke expected to require long-term nursing care facilities
• History of major neurological disease interfering with cognitive functioning
• Prestroke dependence in activities of daily living (Barthel Index<18)
• Insufficient command of the Dutch language to participate and understand questionnaires
• Impossibility to participate in a neuropsychological assessment
• An absolute contraindication to undergo an magnetic resonance imaging MRI-scan of the brain
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Figure 2. An overview of the procedures to be performed on each time point (IPAQ: the International Physical Activities Questionnaire; IQCODE:
Informant Questionnaire on Cognitive Decline in the Elderly; BI: Barthel Index; CIRS: Cumulative Illness Rating Scale; NIHSS: National Institutes of
Health Stroke Scale; mRS: modified Rankin Scale; MRI: Magnetic Resonance Imaging; DTI: Diffusion Tensor Imaging; MoCA: Montreal cognitive
assessment; HADS: Hospital Anxiety and Depression Scale; CLCE-24: CheckList for Cognitive and Emotional problems after stroke; SSQOL: Stroke
Specific Quality of Life Scale; USER-P: Utrecht Scale for Evaluation of Rehabilitation-Participation; PROMIS: Patient-Reported Outcomes Measurement
Information System; SEsx: Self-Efficacy for Symptom Management Scale, NPI-Q: Neuropsychiatric Inventory Questionnaire).
It is expected that the inclusion target will be reached in 1.5
years. Patients are treated the same way as patients that do not
participate in this study. This study does not interfere with
treatment choices or rehabilitation therapy. To account for any
confounding, it will be registered whether patients received
rehabilitation therapy and what kind of therapy was provided.
Moreover, basic demographic data will be collected on the
source population to understand what patient population
participates in the PROCRAS.
Procedure
After informed consent, baseline characteristics will be assessed
during hospital admission (T1). The second assessment takes
places in an outpatient clinic 3-6 weeks after stroke (T2); the
third assessment is a telephone interview 3 months after stroke
(T3); the fourth assessment is another telephone interview 6
months after stroke (T4); and the fifth assessment is performed
in an outpatient clinic 1 year after stroke (T5; see Figure 2). The
PROCRAS study is ongoing for 18 months. From the first 100
patients at T2, 94 completed follow-up until T5.
Measures
Neuropsychological Assessment
The neuropsychological assessment will be performed at T2
and T5. It is designed using the “60-minute protocol” as
proposed in the vascular cognitive impairment harmonization
standards [6]. Textbox 3 lists the domains and associated tests.
Presence or absence of poststroke cognitive impairment is
operationalized according to the criteria for VCD [40]. Patients
will be classified in 3 groups:
1. Unimpaired (performance on all domains is better than 1
SD below appropriate norms)
2. Mild VCD (performance on ≥1 domains is ≥1 SD but <2
SDs below appropriate norms)
3. Major VCD (performance on ≥1 domains is ≥2 SDs below
appropriate norms).
The raw score for each test will be converted into a T-score
corrected for age, gender, and level of education, when possible.
The score for a domain is calculated by averaging the T-scores
of the tests constituting that domain. The T-score is standard
score with a mean of 50 and a SD of 10. For example, a T-score
of 30 translates to 2 SDs below the mean, and a T-score of 60
corresponds to 1 SD above the mean.
Only for the bells test, no normative data are available. An
abnormal score on this test will be defined based on a cutoff
score of a difference of 5 or more omissions between columns
1-3 and columns 5-7 [41].
Magnetic Resonance Imaging
MRI data will be acquired on a Philips 3 Tesla scanner (Intera,
Philips, Best, the Netherlands) for each patient at T2 using a
standardized scanning protocol. The protocol consists of a
sagittal 3D T1-weighted, an axial T2-weighted, an axial fluid
attenuated inversion recovery, an axial diffusion-weighted
imaging, and a DTI sequence. Brain tissue volumes and white
matter hyperintensity volumes will be automatically determined
by brain segmentation, and infarct volumes will be determined
by manual segmentation [42,43].
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Textbox 3. An overview of neuropsychological tests to be performed.
Attention and processing speed
• Reaction time test, Vienna Test System, S1, S2
• Symbol Digit Modalities Test
• Trailmaking test A
(Working) memory and learning
• Wechsler Adult Intelligence Scale (WAIS) Digit Span forward and backward
• The Rey Auditory Verbal Learning Test
Frontal-executive functions
• Controlled Oral Word Association Test
• Hayling test
• Reaction time test Vienna Test System S3
• Trailmaking test B
Language





• Facial Expressions Emotions Stimuli Test
DTI data will be analyzed and processed in ExploreDTI [44],
as described earlier [45]. First, whole-brain fiber tracking will
be performed. Second, the tract reconstructions are parcellated
on 90 gray matter regions using the automated labeling atlas
[46]. Third, a weighted connectivity matrix is obtained by
scaling each present connection between each brain region by
the mean fractional anisotropy of that connection. Finally, global
network efficiency will be calculated by applying graph theory
on the weighted connectivity matrix.
Other Parameters
At T1, demographic factors will be ascertained, apolipoprotein
E (APOE) genotyping will be performed, stroke severity will
be assessed using the National Institutes of Health Stroke Scale
[47], comorbidity using the Cumulative Illness Rating Scale
[48], pre-existent cognitive functioning using the IQCODE [39],
pre-existent physical activities using the short form of the
International Physical Activities Questionnaire [49], and
pre-existent and current activities of daily living using the
Barthel Index [50]. At T2 and T5, motor functioning will be
assessed using the motricity index [51], and emotional
functioning will be assessed using the Hospital Anxiety and
Depression Scale [52] and the Neuropsychiatric Inventory
Questionnaire [53].
At T3 and T5, self-efficacy will be assessed using the
Self-Efficacy for Symptom Management Scale [54]; cognitive
complaints using the Checklist for Cognitive and Emotional
problems after stroke [55]; quality of life using the short version
of the Stroke Specific Quality of Life Scale [56]; participation
using the Utrecht Scale for Evaluation of
Rehabilitation-Participation [57,58]; and global health using
the Patient-Reported Outcomes Measurement Information
System [59,60]. Functional outcome will be assessed with the
modified Rankin scale [61] at T1 and T3-T5.
Aims, Determinants, and Outcomes
Primary Aim
The primary aim of this study is to investigate whether
DTI-based measures of brain connectivity predict cognitive
recovery after 1 year, in addition to other determinants including
patient characteristics and stroke severity. The main DTI marker
that will be used is global network efficiency. This measure
reflects the integration as well as the microstructural integrity
of the white matter.
The primary outcome measure is recovery of cognitive function
in the first year after stroke. This measure will be dichotomized
into cognitive recovery and no cognitive recovery (ie, no change
or deterioration). Cognitive recovery is operationalized as a
transition from a mild VCD at 3-6 weeks (ie, T2) to no disorder
at 1 year (ie, T5), or a transition from a major VCD at T2 to a
mild or no VCD at T5. Hence, only patients with a confirmed
VCD at T2 will be considered for this outcome. Patients that
dropout will not be considered in the primary analyses. Their
outcomes, obtained by telephone interview where possible, will
be reported.
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The secondary outcome measure is deterioration of cognitive
function, operationalized as a transition from a mild VCD at T2
to a major VCD at T5 or a transition from no VCD at T2 to a
mild or a major VCD at T5. For this outcome, only patients
with no or a mild VCD at T2 will be considered.
In secondary analyses, we will also address change in cognitive
performance as a continuous measure, using domain T-scores.
For neuropsychological tests that require writing or drawing,
we will take motor functioning into account as a covariate in
the analysis.
Secondary Aims
A secondary aim is to assess the relation of DTI-based measures
of brain connectivity with patient-reported outcomes and
functional outcome. For this aim, the main DTI marker that will
be used is, again, global network efficiency.
The outcome measures are cognitive complaints, quality of life,
participation, global health, and functional outcome. The first
4 outcome measures will be assessed with questionnaires at 3
months after stroke (ie, T3) and 1 year after stroke (ie, T5). The
questionnaires are repeated at T5 to assess whether a change in
one of these measures occurs. Functional outcome is defined
by the score on the modified Rankin Scale as assessed with a
telephonic interview by a trained researcher at T1, T3, T4, and
T5. All patients with completed follow-up until at least T3 will
be considered for this analysis. Moreover, each of the outcome
measures will be compared between the cognitive impaired
group and the reference group.
Another secondary aim is to assess the feasibility of an extensive
work-up including cognitive assessment and DTI in daily clinical
practice.
The outcome measure will be the proportion of patients that
underwent an MRI scan and neuropsychological assessment
within the timeframe of 3-6 weeks at T2.
Figure 3 visualizes the primary and other outcomes of the
PROCRAS study and the population used in the analyses.
Sample Size Calculation
On the basis of available literature, we estimate an area under
the receiver operating characteristic (ROC) curve of 0.7 for the
prediction model using clinical, neuropsychological, and
conventional imaging parameters, and that approximately half
of the patients with a confirmed cognitive disorder will recover
[3,6,62]. When adding connectivity measures to this model, 200
participants are needed to detect an increase in the area under
the ROC curve of 0.1 or more, with a power of 80% and an
alpha of .05. As a rule of thumb, to reliably measure the weight
of a predictor, at least 10 outcome events per predictor in a
multivariate model are needed. This means that a maximum of
10 predictors can be used in these models. We estimate that
30% of the patients will not complete the full study procedures
until T5, and that 80% of the screen-positive patients will have
a confirmed cognitive disorder at T2. Therefore, we need to
obtain around 300 screen-positive patients with data at T2, to
obtain 200 patients with a confirmed cognitive disorder at T2
and complete follow-up until T5. We will include 1
screen-negative patient for every 5 included screen-positive
patients in the reference group.
Figure 3. Outcomes of the Prediction of Cognitive Recovery After Stroke (PROCRAS) study and the population used in the primary analysis (VCD:
vascular cognitive disorder; MoCA: Montreal Cognitive Assessment).
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First, descriptive statistics will be used. Second, to assess the
additional value of DTI-based measures of brain connectivity,
the 6 strongest predictors from clinical and conventional imaging
parameters will be selected using univariable logistic regression
with cognitive recovery as a dichotomous outcome measure.
The predictive value of the multivariate model including the
strongest predictors from clinical parameters and conventional
imaging markers will be assessed. ROC analyses will be used
to assess whether this predictive value can be improved by
adding network metrics achieved from DTI. The same procedure
will be performed in the prediction of the outcome measures
related to the secondary aim. In the model, we will take the
interval between the stroke and the assessment at T2 as
covariate.
Regulation Statement
The study will be conducted according to the principles of the
Declaration of Helsinki (64th WMA General Assembly,
Fortaleza, Brazil, October 2013) and in accordance with the
Medical Research Involving Human Subjects Act (WMO).
Ethics Committee Approval
The PROCRAS study was approved by the medical ethics
committee of Brabant, based in Tilburg, the Netherlands. Written
informed consent will be obtained from all participants.
Results
At time of acceptance of this paper for publication, this study
has been ongoing for 20 months. Thus far, 252 patients have
provided written informed consent. Final results are expected
in June 2019.
Discussion
The PROCRAS study investigates whether DTI-based measures
of brain connectivity predict cognitive recovery in a large stroke
cohort in daily clinical practice in addition to known predictors
of cognitive outcome. It adds to the existing literature because
of several reasons.
First, it specifically focuses on cognitive recovery, using a
selection of relevant determinants of cognitive outcome after
stroke. As the mechanisms of cognitive recovery or deterioration
after stroke are complex and involve multiple factors, a
prediction model should incorporate each of the most important
factors to provide reliable results. Moreover, by combining
many of the known determinants in a large patient sample, the
coherence between each of these factors can be better
understood.
Second, this study combines the knowledge of different
disciplines working in the stroke field, such as cognitive
neuroscience, neuropsychology, and cognitive rehabilitation.
Approaching VCDs from different angles may help us better
understand how VCDs develop and how they continue to exist.
Moreover, fundamental findings in cognitive neuroscience are
not often translated in clinical practice [63]. If the diagnostic
work-up proves to be feasible, results from this study can be
implemented into clinical practice, benefitting individual stroke
patients.
The study design has several limitations. First, the study focuses
on a relatively specific patient group, because of several
exclusion criteria. For example, patients that cannot undergo a
neuropsychological examination due to severe aphasia are
excluded. We have chosen to exclude patients with risk factors
for a major VCI, as these patients have a low potential to show
cognitive recovery. This would lower the sensitivity to find an
effect. Second, this is a single-center study, which can affect
generalizability of the results. Third, the timeframe of 3 weeks
at T2 is rather broad. This might result in more patient variation,
as patients show most recovery in the first weeks after stroke
[64-66]. However, this timeframe of 3 weeks has been chosen
for pragmatic reasons. At this point in time, information on the
potential of cognitive recovery would help to make decisions
in stroke rehabilitation.
In summary, the results of the PROCRAS study will support
individualized PROCRAS. The results of this study may help
in the psychoeducation of patients, they may add value to
rehabilitation programs in setting realistic and attainable
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